0001140361-19-016669.txt : 20190913 0001140361-19-016669.hdr.sgml : 20190913 20190913184752 ACCESSION NUMBER: 0001140361-19-016669 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20190911 FILED AS OF DATE: 20190913 DATE AS OF CHANGE: 20190913 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Burgstahler David F CENTRAL INDEX KEY: 0001374179 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37906 FILM NUMBER: 191093445 MAIL ADDRESS: STREET 1: C/O WARNER CHILCOTT HOLDINGS CO., LTD. STREET 2: 100 ENTERPRISE DRIVE CITY: ROCKAWAY STATE: NJ ZIP: 07866 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dean Thompson CENTRAL INDEX KEY: 0001069096 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37906 FILM NUMBER: 191093446 MAIL ADDRESS: STREET 1: 65 EAST 55TH STREET, 18TH FLOOR STREET 2: C/O AVISTA CAPITAL PARTNERS CITY: NEW YORK STATE: NY ZIP: 10022 FORMER NAME: FORMER CONFORMED NAME: DEAN THOMPSON DATE OF NAME CHANGE: 19980827 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Avista Capital Partners IV GP, L.P. CENTRAL INDEX KEY: 0001761195 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37906 FILM NUMBER: 191093447 BUSINESS ADDRESS: STREET 1: C/O AVISTA CAPITAL HOLDINGS, LP STREET 2: 65 EAST 55TH STREET, 18TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 212-593-6900 MAIL ADDRESS: STREET 1: C/O AVISTA CAPITAL HOLDINGS, LP STREET 2: 65 EAST 55TH STREET, 18TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Avista Capital Partners (Offshore) IV, L.P. CENTRAL INDEX KEY: 0001664173 STATE OF INCORPORATION: D0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37906 FILM NUMBER: 191093448 BUSINESS ADDRESS: STREET 1: 65 E. 55TH STREET, 18TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 212-593-6900 MAIL ADDRESS: STREET 1: 65 E. 55TH STREET, 18TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Avista Capital Partners IV, L.P. CENTRAL INDEX KEY: 0001664176 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37906 FILM NUMBER: 191093449 BUSINESS ADDRESS: STREET 1: 65 E. 55TH STREET, 18TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 212-593-6900 MAIL ADDRESS: STREET 1: 65 E. 55TH STREET, 18TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Avista Acquisition, LLC CENTRAL INDEX KEY: 0001686388 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37906 FILM NUMBER: 191093450 BUSINESS ADDRESS: STREET 1: 65 EAST 55TH STREET STREET 2: 18TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 212-593-6900 MAIL ADDRESS: STREET 1: 65 EAST 55TH STREET STREET 2: 18TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Avista Acquisition Corp. CENTRAL INDEX KEY: 0001661187 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37906 FILM NUMBER: 191093451 BUSINESS ADDRESS: STREET 1: 65 EAST 55TH STREET STREET 2: 18TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 212 593-6900 MAIL ADDRESS: STREET 1: 65 EAST 55TH STREET STREET 2: 18TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Avista Capital Managing Member IV, LLC CENTRAL INDEX KEY: 0001761175 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37906 FILM NUMBER: 191093452 BUSINESS ADDRESS: STREET 1: C/O AVISTA CAPITAL HOLDINGS, LP STREET 2: 65 EAST 55TH STREET, 18TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 212-593-6900 MAIL ADDRESS: STREET 1: C/O AVISTA CAPITAL HOLDINGS, LP STREET 2: 65 EAST 55TH STREET, 18TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Organogenesis Holdings Inc. CENTRAL INDEX KEY: 0001661181 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 85 DAN ROAD CITY: CANTON STATE: MA ZIP: 02021 BUSINESS PHONE: 781-575-0775 MAIL ADDRESS: STREET 1: 85 DAN ROAD CITY: CANTON STATE: MA ZIP: 02021 FORMER COMPANY: FORMER CONFORMED NAME: Avista Healthcare Public Acquisition Corp. DATE OF NAME CHANGE: 20151215 4 1 form4.xml FORM 4 X0306 4 2019-09-11 0001661181 Organogenesis Holdings Inc. ORGO 0001761175 Avista Capital Managing Member IV, LLC C/O AVISTA CAPITAL PARTNERS 65 EAST 55TH STREET, 18TH FLOOR NEW YORK NY 10022 true true 0001661187 Avista Acquisition Corp. 65 EAST 55TH STREET 18TH FLOOR NEW YORK NY 10022 true true 0001686388 Avista Acquisition, LLC 65 EAST 55TH STREET 18TH FLOOR NEW YORK NY 10022 true true 0001664176 Avista Capital Partners IV, L.P. C/O AVISTA CAPITAL PARTNERS 65 EAST 55TH STREET, 18TH FLOOR NEW YORK NY 10022 true true 0001664173 Avista Capital Partners (Offshore) IV, L.P. C/O AVISTA CAPITAL PARTNERS 65 EAST 55TH STREET, 18TH FLOOR NEW YORK NY 10022 true true 0001761195 Avista Capital Partners IV GP, L.P. C/O AVISTA CAPITAL PARTNERS 65 EAST 55TH STREET, 18TH FLOOR NEW YORK NY 10022 true true 0001069096 Dean Thompson C/O AVISTA CAPITAL PARTNERS 65 EAST 55TH STREET, 18TH FLOOR NEW YORK NY 10022 true true 0001374179 Burgstahler David F C/O AVISTA CAPITAL PARTNERS 65 EAST 55TH STREET, 18TH FLOOR NEW YORK NY 10022 true true Class A common stock 2019-09-11 4 P 0 447000 5.7504 A 18561265 I See Notes Class A common stock 2019-09-12 4 P 0 413900 6.2463 A 18975165 I See Notes This statement is being filed by the following Reporting Persons: Avista Acquisition Corp. (the "Sponsor"); Avista Acquisition LLC, which is the sole shareholder of the Sponsor; Avista Capital Partners IV, L.P. ("ACP Onshore"); Avista Capital Partners (Offshore) IV, L.P. ("ACP Offshore"); Avista Capital Partners IV GP, L.P. ("Avista GP"), which is the general partner of ACP Onshore and ACP Offshore; Avista Capital Managing Member IV, LLC, which is the general partner of Avista GP; Thompson Dean; and David Burgstahler. The number of securities reported represents an aggregate number of shares of Class A common stock of the Issuer ("Common Stock") purchased in multiple market transactions over a range of purchase prices. The price reported represents the weighted average price per share. Each Reporting Person undertakes to provide the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares of Common Stock purchased by the Reporting Person at each separate price within the range. Represents an aggregate of 224,101 shares of Common Stock purchased by ACP Onshore and 222,899 shares of Common Stock purchased by ACP Offshore. Purchase prices range from $5.365 to $5.905 per share, inclusive. Represents 8,779,826 shares of Common Stock owned directly by ACP Onshore, 8,732,748 shares of Common Stock owned directly by ACP Offshore, and 1,048,691 shares of Common Stock owned directly by the Sponsor. Represents an aggregate of 207,507 shares of Common Stock purchased by ACP Onshore and 206,393 shares of Common Stock purchased by ACP Offshore. Purchase prices range from $5.62 to $6.25 per share, inclusive. Represents 8,987,333 shares of Common Stock owned directly by ACP Onshore, 8,939,141 shares of Common Stock owned directly by ACP Offshore, and 1,048,691 shares of Common Stock owned directly by the Sponsor. Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any. Joshua Tamaroff, an employee of an affiliate of the Reporting Persons, serves on the board of directors of the Issuer as a representative of the Reporting Persons. Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests. Exhibit 99.1 Joint Filer Information, incorporated herein by reference. See Exhibit 99.1 for Signatures incorporated herein by reference 2019-09-13 EX-99.1 2 ex99_1.htm EXHIBIT 99.1
Exhibit 99.1

Joint Filer Information

Name of Joint Filer:
Avista Acquisition Corp.
   
Address of Joint Filer:
65 East 55th Street
 
18th Floor
 
New York, NY  10022
   
Relationship of Joint Filer to Issuer:
10% Owner
 
Director
   
Issuer Name and Ticker or Trading Symbol:
Organogenesis Holdings Inc. [ORGO]
   
Date of Earliest Transaction Required to be
 
Reported (Month/Day/Year):
9/11/2019
   
Designated Filer:
Avista Capital Managing Member IV, LLC

Signature:

Avista Acquisition Corp.

/s/ Benjamin Silbert  
Name: Benjamin Silbert
 
Title: Attorney-in-Fact
 

9/13/2019
Date
 
1

Joint Filer Information

Name of Joint Filer:
Avista Acquisition, LLC
   
Address of Joint Filer:
65 East 55th Street
 
18th Floor
 
New York, NY  10022
   
Relationship of Joint Filer to Issuer:
10% Owner
 
Director
   
Issuer Name and Ticker or Trading Symbol:
Organogenesis Holdings Inc. [ORGO]
   
Date of Earliest Transaction Required to be
 
Reported (Month/Day/Year):
9/11/2019
   
Designated Filer:
Avista Capital Managing Member IV, LLC

Signature:

Avista Acquisition, LLC

/s/ Benjamin Silbert  
Name: Benjamin Silbert
 
Title: Attorney-in-Fact
 

9/13/2019
Date
 
2

Joint Filer Information

Name of Joint Filer:
Avista Capital Partners IV, L.P.
   
Address of Joint Filer:
c/o Avista Capital Partners
 
65 East 55th Street, 18th Floor
 
New York, NY 10022
   
Relationship of Joint Filer to Issuer:
10% Owner
 
Director
   
Issuer Name and Ticker or Trading Symbol:
Organogenesis Holdings Inc. [ORGO]
   
Date of Earliest Transaction Required
 
To be Reported:
9/11/2019
   
Designated Filer:
Avista Capital Managing Member IV, LLC

Signature:

Avista Capital Partners IV, L.P.
By: Avista Capital Partners IV GP, L.P.
By: Avista Capital Managing Member IV, LLC, its general partner

/s/ Benjamin Silbert  
Name: Benjamin Silbert
 
Title: Authorized Signatory
 

9/13/2019
Date
 
3


Joint Filer Information

Name of Joint Filer:
Avista Capital Partners (Offshore) IV, L.P.
   
Address of Joint Filer:
c/o Avista Capital Partners
 
65 East 55th Street, 18th Floor
 
New York, NY 10022
   
Relationship of Joint Filer to Issuer:
10% Owner
 
Director
   
Issuer Name and Ticker or Trading Symbol:
Organogenesis Holdings Inc. [ORGO]
   
Date of Earliest Transaction Required
 
To be Reported:
9/11/2019
   
Designated Filer:
Avista Capital Managing Member IV, LLC

Signature:

Avista Capital Partners (Offshore) IV, L.P.
By: Avista Capital Partners IV GP, L.P.
By: Avista Capital Managing Member IV, LLC, its general partner

/s/ Benjamin Silbert  
Name: Benjamin Silbert
 
Title: Authorized Signatory
 

9/13/2019
Date
 
4


Joint Filer Information


Name of Joint Filer:
Avista Capital Partners IV GP, L.P.
   
Address of Joint Filer:
c/o Avista Capital Partners
 
65 East 55th Street, 18th Floor
 
New York, NY 10022
   
Relationship of Joint Filer to Issuer:
10% Owner
 
Director
   
Issuer Name and Ticker or Trading Symbol:
Organogenesis Holdings Inc. [ORGO]
   
Date of Earliest Transaction Required
 
To be Reported:
9/11/2019
   
Designated Filer:
Avista Capital Managing Member IV, LLC

Signature:

Avista Capital Partners IV GP, L.P.
By: Avista Capital Managing Member IV, LLC, its general partner

/s/ Benjamin Silbert  
Name: Benjamin Silbert
 
Title: Authorized Signatory
 

9/13/2019
Date
 
5

Joint Filer Information

Name of Joint Filer:
Avista Capital Managing Member IV, LLC
   
Address of Joint Filer:
c/o Avista Capital Partners
 
65 East 55th Street, 18th Floor
 
New York, NY 10022
   
Relationship of Joint Filer to Issuer:
10% Owner
 
Director
   
Issuer Name and Ticker or Trading Symbol:
Organogenesis Holdings Inc. [ORGO]
   
Date of Earliest Transaction Required
 
To be Reported:
9/11/2019
   
Designated Filer:
Avista Capital Managing Member IV, LLC

Signature:

Avista Capital Managing Member IV, LLC

/s/ Benjamin Silbert  
Name: Benjamin Silbert
 
Title: Authorized Signatory
 

9/13/2019
Date
 
6

Name of Joint Filer:
Thompson Dean
   
Address of Joint Filer:
c/o Avista Capital Partners
 
65 East 55th Street, 18th Floor
 
New York, NY 10022
   
Relationship of Joint Filer to Issuer:
10% Owner
 
Director
   
Issuer Name and Ticker or Trading Symbol:
Organogenesis Holdings Inc. [ORGO]
   
Date of Earliest Transaction Required
 
To be Reported:
9/11/2019
   
Designated Filer:
Avista Capital Managing Member IV, LLC

Signature:

/s/ Benjamin Silbert  
Benjamin Silbert, as attorney-in-fact for
 
Thompson Dean
 

9/13/2019
Date
 
7

Name of Joint Filer:
David Burgstahler
   
Address of Joint Filer:
c/o Avista Capital Partners
 
65 East 55th Street, 18th Floor
 
New York, NY 10022
   
Relationship of Joint Filer to Issuer:
10% Owner
 
Director
   
Issuer Name and Ticker or Trading Symbol:
Organogenesis Holdings Inc. [ORGO]
   
Date of Earliest Transaction Required
 
To be Reported:
9/11/2019
   
Designated Filer:
Avista Capital Managing Member IV, LLC

Signature:

/s/ Benjamin Silbert  
Benjamin Silbert, as attorney-in-fact for
 
David Burgstahler
 

9/13/2019
Date
 

8